OsStic™ Technology
Periarticular Fracture Fixation / Bone Repair
Pre-clinicalFDA Breakthrough Device Designation (2023)
Key Facts
Indication
Periarticular Fracture Fixation / Bone Repair
Phase
Pre-clinical
Status
FDA Breakthrough Device Designation (2023)
Company
About Sanara MedTech
Sanara MedTech is a medical technology company with a mission to improve patient outcomes through advanced healing solutions. The company has a diversified commercial portfolio of surgical biologics and is pioneering a novel bone bioadhesive technology, OsStic™, which received FDA Breakthrough Device Designation in 2023. With a focus on the surgical and orthopedic markets, Sanara leverages clinical education and research to drive adoption of its products.
View full company profile